251 related articles for article (PubMed ID: 34524642)
1. Nivolumab-induced membranous nephropathy in a patient with stage IV lung adenocarcinoma.
Wakabayashi K; Yamamoto S; Hara S; Okawara M; Teramoto K; Ikeda N; Kusunoki Y; Takeji M
CEN Case Rep; 2022 May; 11(2):171-176. PubMed ID: 34524642
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.
Ratanasrimetha P; Reddy VD; Kala J; Tchakarov A; Glass WF; Msaouel P; Lin JS
Front Immunol; 2022; 13():898811. PubMed ID: 35967405
[TBL] [Abstract][Full Text] [Related]
3. PLA2R-positive membranous nephropathy in IgG4-related disease.
Ushio Y; Akihisa T; Karasawa K; Seki M; Kobayashi S; Miyabe Y; Kataoka H; Ito N; Taneda S; Akiyama S; Hebisawa A; Kawano M; Honda K; Hoshino J
BMC Nephrol; 2024 Feb; 25(1):66. PubMed ID: 38395839
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.
Nishizawa Y; Honda K; Aoyama Y; Hosoda Y; Tamura T; Horimoto A; Omae K; Higuchi C; Sakura H; Nitta K; Ogawa T
CEN Case Rep; 2020 Nov; 9(4):395-403. PubMed ID: 32557252
[TBL] [Abstract][Full Text] [Related]
5. Anti-glomerular basement membrane glomerulonephritis concurrent with membranous nephropathy and acute tubular interstitial nephritis in a lung cancer patient treated with pembrolizumab.
Hoshina A; Endo S
CEN Case Rep; 2023 May; 12(2):230-236. PubMed ID: 36401746
[TBL] [Abstract][Full Text] [Related]
6. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
Arai H; Toda N; Kamimatsuse R; Nishioka K; Endo S; Akiyama S; Maruyama S; Matsubara T; Yokoi H; Yanagita M
Intern Med; 2018 Oct; 57(19):2873-2877. PubMed ID: 29709946
[TBL] [Abstract][Full Text] [Related]
7. First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis.
Xu J; Wang X; Weng Q; Feng X; Pan X
BMC Nephrol; 2023 Sep; 24(1):283. PubMed ID: 37752421
[TBL] [Abstract][Full Text] [Related]
8. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
9. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotic syndrome in Crohn's disease].
Boiten HJ; Honkoop P; Smak Gregoor PJ
Ned Tijdschr Geneeskd; 2015; 159():A9264. PubMed ID: 26306485
[TBL] [Abstract][Full Text] [Related]
11. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.
Irifuku T; Satoh A; Tani H; Mandai K; Masaki T
CEN Case Rep; 2020 Feb; 9(1):48-54. PubMed ID: 31605271
[TBL] [Abstract][Full Text] [Related]
12. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
[TBL] [Abstract][Full Text] [Related]
14. A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset.
Yamada T; Itagaki F; Aratani S; Kawasaki S; Terada K; Mugishima K; Kashiwagi T; Shimizu A; Tsuruoka S
CEN Case Rep; 2019 Nov; 8(4):301-307. PubMed ID: 31399881
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors.
Mitropoulou G; Daccord C; Sauty A; Pasche A; Egger B; Aedo Lopez V; Letovanec I; Beigelman-Aubry C; Nicod LP; Lazor R
Respiration; 2020; 99(2):181-186. PubMed ID: 31914436
[TBL] [Abstract][Full Text] [Related]
16. Nivolumab-induced adrenalitis.
Iqbal I; Khan MAA; Ullah W; Nabwani D
BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791986
[TBL] [Abstract][Full Text] [Related]
17. Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.
Chen M; Zhang L; Zhong W; Zheng K; Ye W; Wang M
Front Immunol; 2021; 12():619147. PubMed ID: 34040602
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature.
Saiki R; Katayama K; Saiki H; Fukumori A; Tsujimoto K; Yamawaki M; Tanaka F; Takahashi D; Oda K; Suzuki Y; Murata T; Dohi K
BMC Nephrol; 2024 Feb; 25(1):51. PubMed ID: 38336610
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
[TBL] [Abstract][Full Text] [Related]
20. IgG4-Related Membranous Nephropathy with Acute Nephrotic Syndrome During Successful Steroid Maintenance Treatment for Type 1 Autoimmune Pancreatitis.
Ito H; Ashida K; Demiya M; Motomura S; Nagayama A; Kubo S; Ueda U; Fukami K; Nomura M; Akashi T
Am J Case Rep; 2023 Aug; 24():e940707. PubMed ID: 37592742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
